However, during MSU-induced arthritis, these levels were significantly reduced (Figures 6a, b), indicating that targeting IL-6 can inhibit the activation and phosphorylation of the JAK2-STAT1/3 pathway, thereby alleviating arthritis inflammation. The gene discussed is JAK2; the disease is arthritic joint disease.